Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,872 | 1 | 82.7% |
| Travel and Lodging | $1,043 | 2 | 11.0% |
| Food and Beverage | $604.88 | 35 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $8,915 | 3 | $0 (2023) |
| Abbott Laboratories | $299.10 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $126.05 | 8 | $0 (2023) |
| Gilead Sciences, Inc. | $54.06 | 3 | $0 (2020) |
| Novo Nordisk Inc | $33.64 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $19.46 | 1 | $0 (2019) |
| ABBVIE INC. | $16.17 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $15.84 | 1 | $0 (2021) |
| PFIZER INC. | $14.92 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $14.01 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180.91 | 11 | Abbott Laboratories ($150.73) |
| 2023 | $9,086 | 12 | E.R. Squibb & Sons, L.L.C. ($8,915) |
| 2022 | $68.01 | 4 | Abbott Laboratories ($47.97) |
| 2021 | $29.44 | 2 | Astellas Pharma US Inc ($15.84) |
| 2020 | $36.10 | 2 | Gilead Sciences, Inc. ($36.10) |
| 2019 | $59.98 | 3 | Abbott Laboratories ($22.56) |
| 2018 | $32.58 | 2 | Abbott Laboratories ($20.95) |
| 2017 | $26.77 | 2 | GlaxoSmithKline, LLC. ($26.77) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Diabetes Care | ||||||
| 10/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Insomnia | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Diabetes Care | ||||||
| 07/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Diabetes Care | ||||||
| 04/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: Diabetes Care | ||||||
| 04/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Diabetes Care | ||||||
| 03/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Diabetes Care | ||||||
| 02/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes Care | ||||||
| 01/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: Diabetes Care | ||||||
| 12/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Diabetes Care | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Diabetes Care | ||||||
| 09/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $7,872.00 | General |
| 08/08/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/27/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $739.38 | General |
| 01/27/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $303.97 | General |
| 10/10/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Neuromodulation | ||||||
| 08/08/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 6,183 | 7,223 | $425,026 | $123,041 |
| 2022 | 44 | 7,443 | 8,575 | $507,264 | $144,709 |
| 2021 | 49 | 7,648 | 9,091 | $541,692 | $157,292 |
| 2020 | 49 | 7,446 | 8,807 | $525,556 | $149,195 |
All Medicare Procedures & Services
184 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 245 | $42,875 | $20,472 | 47.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 92 | 121 | $29,040 | $14,362 | 49.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 271 | 290 | $34,800 | $8,413 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 98 | $13,720 | $6,308 | 46.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 82 | 82 | $5,915 | $5,742 | 97.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 280 | 313 | $30,674 | $5,152 | 16.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 288 | 356 | $25,988 | $4,671 | 18.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 236 | 236 | $7,080 | $4,439 | 62.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 264 | 279 | $27,900 | $4,124 | 14.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 249 | 268 | $11,524 | $3,970 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 307 | 472 | $7,552 | $3,965 | 52.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 297 | 380 | $20,520 | $3,923 | 19.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 280 | 330 | $13,860 | $3,142 | 22.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 131 | 153 | $13,005 | $2,757 | 21.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 274 | 304 | $11,856 | $2,687 | 22.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 292 | 343 | $12,348 | $2,610 | 21.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 84 | 84 | $2,940 | $2,596 | 88.3% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 277 | 352 | $10,560 | $2,485 | 23.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 254 | 272 | $21,216 | $2,277 | 10.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $3,400 | $2,203 | 64.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 284 | 365 | $9,125 | $2,161 | 23.7% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 279 | 333 | $10,656 | $2,125 | 19.9% |
| 83735 | Magnesium level | Office | 2023 | 271 | 282 | $11,280 | $1,853 | 16.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $5,445 | $1,805 | 33.1% |
| 84550 | Uric acid level, blood | Office | 2023 | 286 | 367 | $8,074 | $1,626 | 20.1% |
About Dr. Robert Groves, MD
Dr. Robert Groves, MD is a Specialist healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124007356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Groves, MD has received a total of $9,520 in payments from pharmaceutical and medical device companies, with $180.91 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($7,872).
As a Medicare-enrolled provider, Groves has provided services to 28,720 Medicare beneficiaries, totaling 33,696 services with total Medicare billing of $574,237. Data is available for 4 years (2020–2023), covering 184 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Austin, TX
- Active Since 01/16/2006
- Last Updated 06/09/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1124007356
Products in Payments
- FREESTYLE LIBRE 3 (Device) $179.66
- AREXVY (Drug) $99.28
- FREESTYLE LIBRE 2 (Device) $46.28
- PROCLAIM (Device) $29.65
- ANORO (Drug) $26.77
- Proclaim Family of SCS IPGs (Device) $22.56
- Octrode SCS Leads (Device) $20.95
- Rybelsus (Drug) $20.04
- AUSTEDO (Drug) $19.46
- UBRELVY (Drug) $16.17
- MYRBETRIQ (Drug) $15.84
- ELIQUIS (Drug) $14.92
- QUVIVIQ (Drug) $14.01
- Ozempic (Drug) $13.60
- iFuse Implant (Device) $11.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Austin
Dr. Amin Al-Ahmad, Md, MD
Specialist — Payments: $1.0M
Dr. Steven Brotzman, M.d, M.D
Specialist — Payments: $962,398
Dr. Thiru Lakshman, Md, MD
Specialist — Payments: $859,514
Daniel Slaughter, M.d, M.D
Specialist — Payments: $151,066
David Laverty, M.d, M.D
Specialist — Payments: $17,668
Dr. Vivek Mahendru, Md, MD
Specialist — Payments: $15,260